The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Lyell Immunopharma Inc(NASDAQ:LYEL) 
Lyell Immunopharma is an operator of a biotechnology company that develops cellular therapies to cure cancer. South San Francisco, California, United States.
Share this website to your friends
Lyell Immunopharma Days Payable Outstanding ttm (DPO)
Lyell Immunopharma Op Cashflow Per Share ttm
Lyell Immunopharma Free Cashflow Per Share ttm
Lyell Immunopharma Cash Per Share ttm
Lyell Immunopharma P/S ratio ttm
Lyell Immunopharma (GAAP) P/E ratio ttm
Lyell Immunopharma P/B ratio ttm
No extra charts and metrics for this ticker.